On September 14, crypto ETFs attracted a record $292 million in net inflows, with Bitcoin ETFs leading at $160 million, Ethereum ETFs at $121 million, and Solana ETFs at $11 million. BlackRock and Fidelity were the main contributors, especially BlackRock's Bitcoin ETF which accounted for $134.3 million of the inflows. This surge occurred despite macroeconomic pressures like rising bond yields and oil prices, indicating strong institutional interest in crypto assets. The inflows suggest investors are positioning ahead of potential regulatory changes that could further legitimize cryptocurrencies.
The recent record inflows into spot BTC, ETH, and SOL ETFs provide context for crypto market activity. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Sep 15, 2026 22:41 WIB: out of 50 major cryptocurrencies priced on Pluang, only 10 rose while 39 fell. Among notable movers, THETA dropped 8.01% to Rp3.240 with a typical hold time of 77 days and a strong 79% sell order activity, contrasting with BAT which declined 5.96% to Rp1.295 but had 98% buy order activity and a longer hold time of 92 days.
Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting righ...
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
